USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/26585
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAnton, Maria-
dc.contributor.authorMihalachi, Nelea-
dc.contributor.authorBurduniuc, Olga-
dc.date.accessioned2023-12-27T12:15:25Z-
dc.date.available2023-12-27T12:15:25Z-
dc.date.issued2023-
dc.identifier.issn2587-3466-
dc.identifier.issn2587-3458-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/26585-
dc.description.abstractIntroduction. In recent years, the resistance of Klebsiella pneumoniaespecies, both to reserve antimicrobials and to several groups of antimicrobial preparations (MDR), has emerged as a significant global public health concern. K. pneumoniaeexhibits a variety of antimicrobial resistance mechanisms and is a common pathogen responsible for surgical wound infections, gastrointestinal tract infections, urinary tract infections, and community-acquired infections that can trigger nosocomial infection outbreaks. Numerous studies have shown that a majority of infections linked to various medical devices, including urinary and intravascular catheters, were attributed to K. pneumoniae, with approximately 90% of these strains being biofilm producers. According to a report by the CDC, of the 9,000 infections caused by carbapenem-resistant Enterobacteriaceae species documented in 2013, around 80% were attributed to K. pneumoniae. Currently, the global antimicrobial resistance rate for K. pneumoniaeis estimated to be approximately 70%, with a mortality rate ranging between 40% and 70%. Aim. Determination of resistance profiles and detection of resistance mechanisms in K. pneumoniaestrains isolated from clinical biosubstrates. Material and methods. For the determination of K. pneumoniaestrains producing extended-spectrum beta-lactamases and/or carbapenemases, phenotypic tests (double disk synergy test, combined disk test (MastDisk Combi), Amp-C test with cloxacil-lin, Normand Poirel test, MAST CARBA PacE) and molecular genetic tests were performed. Through the Combo Test, Combi Carba Plus tests and the immuno-chromatographic method, the KPC, OXA-48, MBL (NDM, VIM, IMP) type enzymes that confer resistance to the bacteria were highlighted. Confirmation of resistance mechanisms was performed by the molecular-genetic method. Results. Between 2020 and 2022, a total of 867 (76.8%) K. pneumoniaestrains were isolated and reported from urine and 262 (23.2%) strains-from blood and CSF. The resistance profiles of K. pneumoniaeindicate worrying levels of resistance to all groups of antimicrobial preparations, such as: penicillins –76.5%, fluoroquinolones –78.4%, 3rd generation cephalosporins –82.8%, 4th generation cephalo-sporins –64, 1%, aminoglycosides –71.6%, including carbapenems –40.5% and colistin –23.5%. ESBL-producing strains are increasing, from 17.5% confirmed strains in 2020 to 33.6% confirmed isolates in 2022. Among the 66.5% strains suspected of producing carbapenemases, 35.7% isolates were identified by the immunochromatographic method, including OXA-48 type presented 34.4% strains of K. pneumoniae, NDM type –13.9%, IMP type –4.9% strains, KPC and VIM type –0.2% strains each. Through the multiplex PCR, 29.4% strains of K. pneumoniaewith resistance genes were confirmed. In 28.8% of isolates, the blaOXA-48 gene was determined. Alarmingly, 10.0% strains showed 2 or more resistance mechanisms simultaneously. Conclusions. K. pneumonia is the most common pathogen involved in the etiology of invasive infections. The resistance levels of this species have reached alarming levels, even with reserve antimicrobials. In the investigated K. pneumoniaespecies, a wide array of resistance enzymes was identified, with the most frequent being OXA-48, followed by NDM.en_US
dc.language.isoenen_US
dc.publisherAsociația de Biosiguranță și Biosecuritate din Republica Moldovaen_US
dc.relation.ispartofOne Health & Risk Managementen_US
dc.subjectmultidrug-resistant K. pneumoniaen_US
dc.subjectresistance mechanismsen_US
dc.subjectbeta-lactamasesen_US
dc.subjectcarbapenemasesen_US
dc.subjectresistance genesen_US
dc.titleAnalysis of antimicrobial resistance in clinical strains of Klebsiella pneumoniaeen_US
dc.typeOtheren_US
Appears in Collections:One Health & Risk Management noiembrie 2023, Ediție specială

Files in This Item:
File Description SizeFormat 
591_Manuscript_1672_1_10_20231215.pdf257.97 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback